Cost Effectiveness of Amphotericin B plus G-CSF Compared with Amphotericin B Monotherapy: Treatment of Presumed Deep-Seated Fungal Infection in Neutropenic Patients in the UK

By Flynn T.N.  

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 543-550

Adis International

Access to resources Recommend Favorite

Amphotericin B lipid complex for the treatment of invasive fungal infections

By Linden Peter K  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 2099-2110

Informa Healthcare

Access to resources Recommend Favorite

Pharmacoeconomic Analysis of Amphotericin B Lipid Complex versus Liposomal Amphotericin B in the Treatment of Fungal Infections

By Kuti J.L.  

PharmacoEconomics, Vol. 22, Iss. 5, 2004-01 ,pp. : 301-310

Adis International

Access to resources Recommend Favorite

Development of Liposomal Amphotericin B Dry Powder Inhaler Formulation

By Shah S.   Misra Ambikanandan  

Drug Delivery, Vol. 11, Iss. 4, 2004-01 ,pp. : 247-253

Informa Healthcare

Access to resources Recommend Favorite

Liposomal Amphotericin B: A Review of its Use as Empirical Therapy in Febrile Neutropenia and in the Treatment of Invasive Fungal Infections

By Moen Marit D.   Lyseng-Williamson Katherine A.   Scott Lesley J.  

Drugs, Vol. 69, Iss. 3, 2009-02 ,pp. : 361-392

Adis International

Access to resources Recommend Favorite